Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000244929 | SCV000227232 | benign | not specified | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003891716 | SCV000307968 | benign | FLNC-related disorder | 2023-03-28 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Gene |
RCV001532118 | SCV000522734 | benign | not provided | 2018-03-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000530980 | SCV000651097 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000244929 | SCV001475126 | benign | not specified | 2019-12-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001532118 | SCV001747530 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |
Ambry Genetics | RCV002354448 | SCV002657079 | benign | Cardiovascular phenotype | 2019-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002485136 | SCV002801292 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2022-01-10 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486726 | SCV004240664 | benign | Cardiomyopathy | 2022-11-17 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000244929 | SCV001919147 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001532118 | SCV001928322 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001532118 | SCV001957378 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001532118 | SCV001964164 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000244929 | SCV002035866 | benign | not specified | no assertion criteria provided | clinical testing |